Erschienen in:
15.06.2016 | Original Article—Liver, Pancreas, and Biliary Tract
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study
verfasst von:
Takashi Taida, Makoto Arai, Tatsuo Kanda, Shuhei Hige, Yoshiyuki Ueno, Fumio Imazeki, Namiki Izumi, Eiji Tanaka, Noboru Shinkai, Kentaro Yoshioka, Yasunari Nakamoto, Shuhei Nishiguchi, Masataka Tsuge, Masanori Abe, Michio Sata, Hiroshi Yatsuhashi, Akio Ido, Kazuhiko Kita, Ryousaku Azemoto, Yoshio Kitsukawa, Nobuaki Goto, Osamu Yokosuka
Erschienen in:
Journal of Gastroenterology
|
Ausgabe 1/2017
Einloggen, um Zugang zu erhalten
Abstract
Background
Hepatitis B e antigen (HBeAg)-negative inactive carriers, the majority of hepatitis B virus (HBV) carriers, are considered to have a good prognosis. The definition of the inactive HBV carrier state has been based on HBV DNA and alanine aminotransferase (ALT) levels. Here we conducted a prospective study involving 18 hospitals to clarify the prognosis of HBeAg-negative inactive carriers.
Methods
Three hundred eighty-eight HBeAg-negative inactive carriers at the baseline were observed prospectively from January 2011 to November 2015. We evaluated the primary end point, defined as the development of cirrhosis, hepatocellular carcinoma (HCC), or liver-related death. Also, we analyzed the factors associated with inactive carrier dropout and markedly increased levels of ALT or HBV DNA or both during the follow-up period.
Results
At the baseline, the mean age was 57.5 ± 13.1 years and 42 % of patients were male. No individual developed cirrhosis, HCC, or liver-related death during the follow-up period (1035 ± 252 days). Loss of inactive carrier status was seen in 75 patients (19.3 %). Factors associated with failure to meet the inactive carrier criteria in the multivariate analysis were the levels of ALT (hazard ratio 1.13, 95 % confidence interval 1.07–1.19, p < 0.001), HBV DNA (hazard ratio 2.70, 95 % confidence interval 1.63–4.49, p < 0.001), and γ-glutamyl transpeptidase (hazard ratio 1.01, 95 % confidence interval 1.00–1.02, p = 0.003) at the baseline.
Conclusions
Most inactive carriers in Japan had a good prognosis. However, despite the short observation period, some patients had loss of IC status. The long-term prognosis of inactive carriers remains unclear; therefore, careful follow-up of inactive carriers is needed.